| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $739.0M | +31.0% |
| R&D Expense | $347.8M | -5.3% |
| SG&A Expense | $180.1M | +15.6% |
| Operating Income | -$443.6M | +21.4% |
| Pre-tax Income | -$435.1M | +9.1% |
| Income Tax | $1.3M | +87.4% |
| Net Income | -$436.4M | +9.0% |
| EPS (Basic) | -$3.56 | +16.8% |
| EPS (Diluted) | -$3.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $525.5M | -53.6% |
| Accounts Receivable | $110.3M | +24.2% |
| Inventory | $71.1M | +14.7% |
| Current Assets | $1.06B | -21.7% |
| Total Assets | $1.49B | -16.8% |
| Current Liabilities | $225.6M | +9.6% |
| Total Liabilities | $1.63B | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$239.9M | +26.2% |
| Capital Expenditures | $35.1M | +71.3% |
| Investing Cash Flow | -$261.3M | -131.1% |
| Financing Cash Flow | -$996K | -100.2% |
| Free Cash Flow | -$274.9M | +20.4% |
| +16.8% |
| Stockholders' Equity |
| -$139.6M |
| -188.0% |